AAAAAA
Results: 1-25/34
Authors:
SMITH JB
WICKSTROM E
Citation: Jb. Smith et E. Wickstrom, ANTISENSE C-MYC AND IMMUNOSTIMULATORY OLIGONUCLEOTIDE INHIBITION OF TUMORIGENESIS IN A MURINE B-CELL LYMPHOMA TRANSPLANT MODEL, Journal of the National Cancer Institute, 90(15), 1998, pp. 1146-1154
Authors:
WICKSTROM E
SMITH JB
Citation: E. Wickstrom et Jb. Smith, DNA COMBINATION THERAPY TO STOP TUMOR-GROWTH, The cancer journal from Scientific American, 4, 1998, pp. 43-47
Authors:
GRAY GD
WICKSTROM E
Citation: Gd. Gray et E. Wickstrom, RAPID MEASUREMENT OF MODIFIED OLIGONUCLEOTIDE LEVELS IN PLASMA SAMPLES WITH A FLUOROPHORE SPECIFIC FOR SINGLE-STRANDED-DNA, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(3), 1997, pp. 133-140
Authors:
WICKSTROM E
Citation: E. Wickstrom, ANTISENSE C-MYC INHIBITION OF LYMPHOMA GROWTH, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(3), 1997, pp. 225-228
Authors:
DELONG RK
NOLTING A
FISHER M
CHEN Q
WICKSTROM E
KLIGSHTEYN M
DEMIRDJI S
CARUTHERS M
JULIANO RL
Citation: Rk. Delong et al., COMPARATIVE PHARMACOKINETICS, TISSUE DISTRIBUTION, AND TUMOR ACCUMULATION OF PHOSPHOROTHIOATE, PHOSPHORODITHIOATE, AND METHYLPHOSPHONATE OLIGONUCLEOTIDES IN NUDE-MICE, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(2), 1997, pp. 71-77
Authors:
BASU S
WICKSTROM E
Citation: S. Basu et E. Wickstrom, SYNTHESIS AND CHARACTERIZATION OF A PEPTIDE NUCLEIC-ACID CONJUGATED TO A D-PEPTIDE ANALOG OF INSULIN-LIKE-GROWTH-FACTOR-1 FOR INCREASED CELLULAR UPTAKE, Bioconjugate chemistry, 8(4), 1997, pp. 481-488
Authors:
SMITH JB
WICKSTROM E
Citation: Jb. Smith et E. Wickstrom, INHIBITION OF TUMORIGENESIS IN A MURINE B-CELL LYMPHOMA TRANSPLANT MODEL BY C-MYC COMPLEMENTARY OLIGONUCLEOTIDES, Cancer gene therapy, 4(5), 1997, pp. 329-329
Authors:
CLEAVER SH
WICKSTROM E
Citation: Sh. Cleaver et E. Wickstrom, TN7 TRANSPOSITION INTO A HUMAN SEQUENCE, The FASEB journal, 11(9), 1997, pp. 1376-1376
Authors:
GRAY GD
TOWNSEND R
HAYASAKA H
KORNGOLD R
WICKSTROM E
Citation: Gd. Gray et al., IMMUNE CELL INVOLVEMENT IN ANTI-C-MYC DNA PREVENTION OF TUMOR-FORMATION IN A MOUSE MODEL OF BURKITTS-LYMPHOMA, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1727-1730
Authors:
NOLTING A
DELONG RK
FISHER MH
WICKSTROM E
POLLACK GM
JULIANO RL
BROUWER KLR
Citation: A. Nolting et al., HEPATIC DISTRIBUTION AND CLEARANCE OF ANTISENSE OLIGONUCLEOTIDES IN THE ISOLATED-PERFUSED RAT-LIVER, Pharmaceutical research, 14(4), 1997, pp. 516-521
Authors:
BASU S
WICKSTROM E
Citation: S. Basu et E. Wickstrom, TEMPERATURE AND SALT DEPENDENCE OF HIGHER-ORDER STRUCTURE FORMATION BY ANTISENSE C-MYC AND C-MYB PHOSPHOROTHIOATE OLIGODEOXYRIBONUCLEOTIDESCONTAINING TETRAGUANYLATE TRACTS, Nucleic acids research, 25(7), 1997, pp. 1327-1332
Authors:
MAZUMDER A
UCHIDA H
NEAMATI N
SUNDER S
JAWORSKAMASLANKA M
WICKSTROM E
ZENG F
JONES RA
MANDES RF
CHENAULT HK
POMMIER Y
Citation: A. Mazumder et al., PROBING INTERACTIONS BETWEEN VIRAL-DNA AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE USING DINUCLEOTIDES, Molecular pharmacology, 51(4), 1997, pp. 567-575
Authors:
GRAY GD
BASU S
WICKSTROM E
Citation: Gd. Gray et al., TRANSFORMED AND IMMORTALIZED CELLULAR UPTAKE OF OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATES, 3'-ALKYLAMINO OLIGODEOXYNUCLEOTIDES, 2'-O-METHYL OLIGORIBONUCLEOTIDES, OLIGODEOXYNUCLEOSIDE METHYLPHOSPHONATES, AND PEPTIDE NUCLEIC-ACIDS, Biochemical pharmacology, 53(10), 1997, pp. 1465-1476
Authors:
FU ZF
WICKSTROM E
JIANG M
CORISDEO S
YANG J
DIETZSCHOLD B
KOPROWSKI H
Citation: Zf. Fu et al., INHIBITION OF RABIES VIRUS-INFECTION BY AN OLIGODEOXYNUCLEOTIDE COMPLEMENTARY TO RABIES VIRUS GENOMIC RNA, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 6(2), 1996, pp. 87-93
Authors:
WICKSTROM E
MAIZELS M
SABBAGHA RE
TAMURA RK
COHEN LC
PERGAMENT E
Citation: E. Wickstrom et al., ISOLATED FETAL PYELECTASIS - ASSESSMENT OF RISK FOR POSTNATAL UROPATHY AND DOWN-SYNDROME, Ultrasound in obstetrics & gynecology, 8(4), 1996, pp. 236-240
Authors:
LEBEDEV AV
WICKSTROM E
Citation: Av. Lebedev et E. Wickstrom, THE CHIRALITY PROBLEM IN P-SUBSTITUTED OLIGONUCLEOTIDES, Perspectives in drug discovery and design, 4, 1996, pp. 17-40
Authors:
BASU S
WICKSTROM E
Citation: S. Basu et E. Wickstrom, TETRAPLEX FORMATION BY PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE SEQUENCES USED IN ANTISENSE EXPERIMENTS TARGETED TO C-MYC AND C-MYB MESSENGER-RNA, The FASEB journal, 10(6), 1996, pp. 2848-2848
Authors:
BASU S
WICKSTROM E
Citation: S. Basu et E. Wickstrom, AN EFFICIENT METHOD OF IMPROVING THE CELLULAR UPTAKE OF PEPTIDE NUCLEIC-ACIDS, The FASEB journal, 10(3), 1996, pp. 2574-2574
Authors:
GRAY GD
WICKSTROM E
Citation: Gd. Gray et E. Wickstrom, EVALUATION OF ANCHORAGE-INDEPENDENT PROLIFERATION IN TUMORIGENIC CELLS USING THE REDOX DYE ALAMARBLUE(TM), BioTechniques, 21(5), 1996, pp. 780
Authors:
LEBEC C
WICKSTROM E
Citation: C. Lebec et E. Wickstrom, STEREOSPECIFIC GRIGNARD-ACTIVATED SOLID-PHASE SYNTHESIS OF DNA METHYLPHOSPHONATE DIMERS, Journal of organic chemistry, 61(2), 1996, pp. 510-513
Authors:
HUANG Y
SNYDER R
KLIGSHTEYN M
WICKSTROM E
Citation: Y. Huang et al., PREVENTION OF TUMOR-FORMATION IN A MOUSE MODEL OF BURKITTS-LYMPHOMA BY 6 WEEKS OF TREATMENT WITH ANTI-C-MYC DNA PHOSPHOROTHIOATE, Molecular medicine, 1(6), 1995, pp. 647-658
Authors:
CLEAVER S
WICKSTROM E
Citation: S. Cleaver et E. Wickstrom, MOLECULAR MODELING OF THE TOPOISOMERASE-I DNA-BINDING SITE, The FASEB journal, 9(6), 1995, pp. 1466-1466
Authors:
HUANG Y
SNYDER R
KLIGSHTEYN M
WICKSTROM E
Citation: Y. Huang et al., PREVENTION OF B-CELL LYMPHOMA IN EU-MYC TRANSGENIC MICE BY 6 WEEKS OFTREATMENT WITH ANTI-C-MYC DNA PHOSPHOROTHIOATE, The FASEB journal, 9(3), 1995, pp. 409-409
Authors:
HUGHES JA
AVRUTSKAYA AV
BROUWER KLR
WICKSTROM E
JULIANO RL
Citation: Ja. Hughes et al., RADIOLABELING OF METHYLPHOSPHONATE AND PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND EVALUATION OF THEIR TRANSPORT IN EVERTED RAT JEJUNUM SACS, Pharmaceutical research, 12(6), 1995, pp. 817-824
Authors:
GRAY GD
WICKSTROM E
Citation: Gd. Gray et E. Wickstrom, CELLULAR UPTAKE OF MODIFIED ANTISENSE DNA, Protein engineering, 8, 1995, pp. 73-73